Walleye Capital’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Walleye Capital’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-56,799	Closed	-$2.61K	–	5168
2023 Q1	$2.61K	Buy	56,799 +4,426	+8%	+$190	﹤0.01%	3742
2022 Q4	$560	Hold	52,373	–	–	﹤0.01%	3090
2022 Q3	$5K	Hold	52,373	–	–	﹤0.01%	2951
2022 Q2	$7K	Sell	52,373 -4,210	-7%	-$852	﹤0.01%	2079
2022 Q1	$16K	Buy	+56,583	New	+$20.6K	﹤0.01%	2014

Walleye Capital's IQMDW Position: Q2 2023 in Review

Walleye Capital sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 56,799 shares — an estimated $2.61K sold.

Walleye Capital first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $16K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Walleye Capital reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Walleye Capital sold 56,799 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $2.61K.
Walleye Capital first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
Walleye Capital's Intelligent Medicine Acquisition Corp. Warrant position peaked at $16K in Q1 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.